JP2009523007A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523007A5
JP2009523007A5 JP2007536171A JP2007536171A JP2009523007A5 JP 2009523007 A5 JP2009523007 A5 JP 2009523007A5 JP 2007536171 A JP2007536171 A JP 2007536171A JP 2007536171 A JP2007536171 A JP 2007536171A JP 2009523007 A5 JP2009523007 A5 JP 2009523007A5
Authority
JP
Japan
Prior art keywords
sequence
seq
replaced
adenovirus
batch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007536171A
Other languages
English (en)
Japanese (ja)
Other versions
JP4843613B2 (ja
JP2009523007A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/055183 external-priority patent/WO2006040330A2/en
Publication of JP2009523007A publication Critical patent/JP2009523007A/ja
Publication of JP2009523007A5 publication Critical patent/JP2009523007A5/ja
Application granted granted Critical
Publication of JP4843613B2 publication Critical patent/JP4843613B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007536171A 2004-10-13 2005-10-12 改良されたアデノウイルスベクターおよびその使用方法 Expired - Fee Related JP4843613B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US61846904P 2004-10-13 2004-10-13
EP04105005 2004-10-13
EP04105005.5 2004-10-13
US60/618,469 2004-10-13
US69772405P 2005-07-08 2005-07-08
US60/697,724 2005-07-08
PCT/EP2005/055183 WO2006040330A2 (en) 2004-10-13 2005-10-12 Improved adenoviral vectors and uses thereof

Publications (3)

Publication Number Publication Date
JP2009523007A JP2009523007A (ja) 2009-06-18
JP2009523007A5 true JP2009523007A5 (enExample) 2010-10-28
JP4843613B2 JP4843613B2 (ja) 2011-12-21

Family

ID=34929696

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007536171A Expired - Fee Related JP4843613B2 (ja) 2004-10-13 2005-10-12 改良されたアデノウイルスベクターおよびその使用方法

Country Status (6)

Country Link
JP (1) JP4843613B2 (enExample)
CN (1) CN101072879B (enExample)
AT (1) ATE492643T1 (enExample)
DE (1) DE602005025512D1 (enExample)
ES (1) ES2358523T3 (enExample)
ZA (1) ZA200702792B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010085984A1 (en) * 2009-02-02 2010-08-05 Okairos Ag Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
WO2011022002A1 (en) * 2009-08-18 2011-02-24 The Rockefeller University Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
CN102844329B (zh) * 2010-04-14 2016-01-20 财团法人牧岩生命工学研究所 分离自猿腺病毒血清型19的六邻体、其高变区和使用其的嵌合型腺病毒
CN103370411B (zh) * 2010-12-14 2016-05-04 美国卫生和人类服务部 腺病毒血清型26和血清型35线状病毒疫苗
CN102199616B (zh) * 2011-03-07 2013-04-24 首都医科大学附属北京佑安医院 Hiv-1表型耐药检测载体及其构建方法
JP6757120B2 (ja) * 2011-10-05 2020-09-16 ジェンヴェック エルエルシー アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法
AP2014007993A0 (en) * 2012-03-22 2014-10-31 Crucell Holland Bv Vaccine against RSV
KR102697827B1 (ko) 2015-07-28 2024-08-23 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 키메릭 항원 수용체를 발현하는 변형된 단핵세포/대식세포 및 그의 용도
CA3045892A1 (en) * 2016-12-12 2018-06-21 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof
CN106868047B (zh) * 2017-03-07 2020-04-28 南方医科大学 一种重组腺病毒载体及其构建方法和用途
JP7274222B2 (ja) * 2017-07-05 2023-05-16 ノイスコム アーゲー 非ヒト大型類人猿アデノウイルスの核酸配列及びアミノ酸配列、それを含有するベクター、並びにその使用
CN107267469B (zh) * 2017-08-22 2020-06-16 广州医科大学附属第一医院 纤毛蛋白嵌合型重组人b型腺病毒及其制备方法
US11236361B2 (en) * 2017-10-31 2022-02-01 Janssen Vaccines & Prevention B.V. Adenovirus and uses thereof
EP3704256A1 (en) * 2017-10-31 2020-09-09 Janssen Vaccines & Prevention B.V. Adenovirus vectors and uses thereof
CN112543766A (zh) 2018-04-03 2021-03-23 斯特里迪比奥公司 抗体逃避性病毒载体
EP3906038A4 (en) * 2018-11-21 2022-06-01 Mayo Foundation for Medical Education and Research ADENOVIRUS AND METHODS OF USE OF ADENOVIRUS
WO2020172509A1 (en) * 2019-02-21 2020-08-27 Unleash Immuno Oncolytics, Inc. Oncolytic adenoviral vector and methods of use
EP4161536A4 (en) 2020-06-04 2024-08-14 Carisma Therapeutics Inc. Novel constructs for chimeric antigen receptors
CN114262692A (zh) * 2021-11-30 2022-04-01 华中科技大学同济医学院附属同济医院 一种携带tmvp1和hsv-tk的溶瘤腺病毒重组体，其构建方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127525A (en) * 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
US5922315A (en) * 1997-01-24 1999-07-13 Genetic Therapy, Inc. Adenoviruses having altered hexon proteins
ES2375557T3 (es) * 2001-06-22 2012-03-02 The Trustees Of The University Of Pennsylvania Adenovirus recombinantes que comprenden prote�?nas de adenovirus de simios y usos de los mismos.

Similar Documents

Publication Publication Date Title
JP2009523007A5 (enExample)
Havenga et al. Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER. C6 cells
Akusjarvi Temporal regulation of adenovirus major late alternative RNA splicing
Parks et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal
JP4787936B2 (ja) 癌処理への使用のためのキメラアデノウィルス
Reddy et al. Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3
JP5097714B2 (ja) Ｅ１領域内の発現カセットと不活性化されたｅ２ｂポリメラーゼを有するアデノウイルス発現ベクター
Michou et al. Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors
JP2020022459A5 (enExample)
Von Seggern et al. Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein
JP2014516536A5 (enExample)
JP6277213B2 (ja) サルアデノウイルスベクターの増殖方法
CN1382218A (zh) 溶瘤腺病毒
JP2005505286A5 (enExample)
JP2018523980A5 (enExample)
JP2008518591A5 (enExample)
Roy et al. Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses
US6844192B2 (en) Adenovirus E4 protein variants for virus production
Lusky et al. Regulation of adenovirus-mediated transgene expression by the viral E4 gene products: requirement for E4 ORF3
Stone et al. The complete nucleotide sequence, genome organization, and origin of human adenovirus type 11
Sirena et al. The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3
JP2008510493A5 (enExample)
JP2011521661A5 (enExample)
CN1655827A (zh) 腺病毒和编码其的核酸的新应用
Khatri et al. Gene Expression by Atypical Recombinant Ovine Adenovirus Vectors during Abortive Infection of Human and Animal Cellsin Vitro